Круглосуточно

+7 (965) 177 17 74


бесплатно по России
cbc40e52
img

цаталодж 2149996 абоут правовайа_информатсийа

img

5-ASA preparations have very weak immunosuppressive activity. There are no reports that these drugs are associated with an increased risk of infection, and studies evaluating the safety profile of 5-ASA do not show an increased risk of serious or opportunistic infections. Treatment with 5-ASA should be continued without concern for an increased risk of infection or severe COVID-19. If the patient is in contact with a patient with COVID-19 or develops COVID-19, treatment with 5-ASA should be continued.

Таким образом, АГ была и остается очень важной медицинской и социальной проблемой, которая требует соответствующего внимания не только со стороны учреждений здравоохранения и медицинских работников, но и руководства Минздрава и государства. Только совместными усилиями представителей медицинской науки, здравоохранения и всего общественного общества можно достичь повышения эффективности борьбы с этим заболеванием.

The criteria for assessing their own health by young people (25-44 years old - according to the WHO classification) were distributed as follows: almost half of the respondents, regardless of gender, rated their own health as "good"; every 4th of those surveyed - as "very good"; “Mediocre” health was noted by every fifth woman and every tenth person; almost the same was the proportion of respondents who rated their own health as “bad”; the level of subjective assessment of "excellent health" was observed in every tenth man, while in women it was absent.

img

When transitioning to biological therapy, subcutaneous administration should be considered to limit patient contact with the healthcare facility. Selective switching from intravenous infliximab to subcutaneous anti-TNF is not recommended as it may increase the risk of relapse. If the patient is in contact with a COVID-19 person, withdrawal of anti-TNF therapy for 2 weeks should be considered.


Контакты
  • г. Москва,
  • м. Отрадное,
  • Высоковольтный проезд, д. 1, к. 7

+7 (965) 177 17 74

  • Режим работы:

10:00 до 20:00 пн-пт

10:00 до 18:00 сб-вс

Забор анализов:

9:00 до 20:00 пн-пт

9:00 до 18:00 сб-вс